Aviva PLC Codexis, Inc. Transaction History

Aviva PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$18.08 - $28.8 $1.9 Million - $3.03 Million	-105,216 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$11.7 - $23.41 $998,009 - $2 Million	-85,300 Reduced 44.77%	105,216 $2.3 Million
Q3 2020 Nov 12, 2020	SELL	$11.21 - $13.82 $172,869 - $213,118	-15,421 Reduced 7.49%	190,516 $2.24 Million
Q2 2020 Aug 13, 2020	SELL	$9.8 - $12.77 $1.28 Million - $1.66 Million	-130,126 Reduced 38.72%	205,937 $2.35 Million
Q1 2020 May 14, 2020	BUY	$8.78 - $18.6 $1.85 Million - $3.91 Million	210,381 Added 167.39%	336,063 $3.75 Million
Q4 2019 Feb 10, 2020	BUY	$13.12 - $17.06 $1.65 Million - $2.14 Million	125,682 New	125,682 $2.01 Million

126

48.2M

33.7K

20.2K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $202M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.